I agree that this site is using cookies. You can find further informations here.
X
LaPlant, Betsy R.
106  results:
Search for persons X
?
1

A phase II study of ibrutinib in combination with ixazomib ..:

Parrondo, Ricardo D. ; Dutta, Navnita ; LaPlant, Betsy R....
British Journal of Haematology.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

AT-101 Enhances the Antitumor Activity of Lenalidomide in P..:

Ailawadhi, Sikander ; Parrondo, Ricardo D. ; Dutta, Navnita...
Cancers.  15 (2023)  2 - p. 477 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Ibrutinib, lenalidomide and dexamethasone in patients with ..:

Ailawadhi, Sikander ; Parrondo, Ricardo D. ; Moustafa, Muhamad Alhaj...
Hematological Oncology.  40 (2022)  4 - p. 695-703 , 2022
Link: https://doi.org/10.1002/..
 
?
4

Phase 2 trial of ixazomib, cyclophosphamide, and dexamethas..:

Muchtar, Eli ; Gertz, Morie A. ; LaPlant, Betsy R....
Blood Advances.  6 (2022)  18 - p. 5429-5435 , 2022
Link: https://doi.org/10.1182/..
 
?
5

Fluorodeoxyglucose-Positron Emission Tomography Predicts Bo..:

St-Pierre, Frédérique ; Broski, Stephen M. ; LaPlant, Betsy R....
The Oncologist.  25 (2020)  8 - p. 689-695 , 2020
Link: https://doi.org/10.1634/..
 
?
6

Bone involvement on PET/CT predicts event‐free survival in ..:

St‐Pierre, Frederique ; Broski, Stephen M. ; LaPlant, Betsy R....
British Journal of Haematology.  191 (2020)  2 - p. , 2020
Link: https://doi.org/10.1111/..
 
?
7

Outcomes of Autologous Stem Cell Transplant Consolidation i..:

Khurana, Arushi ; Micallef, Ivana N. ; LaPlant, Betsy R....
Biology of Blood and Marrow Transplantation.  26 (2020)  12 - p. 2217-2222 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Detection of extranodal and spleen involvement by FDG‐PET i..:

St‐Pierre, Frédérique ; Broski, Stephen M. ; LaPlant, Betsy R....
American Journal of Hematology.  94 (2019)  7 - p. 786-793 , 2019
Link: https://doi.org/10.1002/..
 
?
9

CNS relapse in patients with DLBCL treated with lenalidomid..:

Ayed, Ayed O. ; Chiappella, Annalisa ; Pederson, Levi...
Blood Cancer Journal.  8 (2018)  7 - p. , 2018
Link: https://doi.org/10.1038/..
 
?
10

Efficacy of the oral mTORC1 inhibitor everolimus in relapse..:

Bennani, N. Nora ; LaPlant, Betsy R. ; Ansell, Stephen M....
American Journal of Hematology.  92 (2017)  5 - p. 448-453 , 2017
Link: https://doi.org/10.1002/..
 
?
11

MYD88 mutation status does not impact overall survival in W..:

Abeykoon, Jithma P. ; Paludo, Jonas ; King, Rebecca L....
American Journal of Hematology.  93 (2017)  2 - p. 187-194 , 2017
Link: https://doi.org/10.1002/..
 
?
12

Long‐term follow‐up of chemoimmunotherapy with rituximab, o..:

Witzig, Thomas E. ; Johnston, Patrick B. ; LaPlant, Betsy R....
American Journal of Hematology.  92 (2017)  10 - p. 1004-1010 , 2017
Link: https://doi.org/10.1002/..
 
?
13

A randomized phase II trial comparing chemoimmunotherapy wi..:

Kay, Neil E. ; Strati, Paolo ; LaPlant, Betsy R....
Oncotarget.  7 (2016)  48 - p. 78269-78280 , 2016
Link: https://doi.org/10.18632..
 
?
14

Elevated soluble IL‐2Rα, IL‐8, and MIP‐1β levels are associ..:

Sonbol, Mohamad B. ; Maurer, Matthew J. ; Stenson, Mary J....
American Journal of Hematology.  89 (2014)  12 - p. , 2014
Link: https://doi.org/10.1002/..
 
?
15

5.24 Pentostatin, Alemtuzumab, and Low-Dose Rituximab Is Ef..:

Zent, Clive S. ; LaPlant, Betsy R. ; Link, Brian...
Clinical Lymphoma Myeloma and Leukemia.  11 (2011)  - p. S258-S259 , 2011
Link: https://doi.org/10.1016/..
 
1-15